OTHER INFORMATION
−Removed: No information was required to be disclosed in
−Removed: a Current Report on Form 8-K during the three months ended September 30, 2025, but was not reported.
−Removed: None of our directors or “officers,”
−Removed: as defined in Rule 16a-1(f) under the Exchange Act, adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1
−Removed: trading plan or arrangement, as defined in Item 408(c) of Regulation S-K, during the fiscal quarter ended September 30, 2025.
+Added: No information was required to be disclosed in a Current Report on Form 8 -K during the three months ended March 31, 2026 , but was not reported.
+Added: None of our directors or “officers,” as defined in Rule 16a - 1 (f) under the Exchange Act, adopted or terminated a Rule 10b5 - 1 trading plan or arrangement or a non-Rule 10b5 - 1 trading plan or arrangement, as defined in Item 408 (c) of Regulation S-K, during the fiscal quarter ended March 31, 2026 .
Amended and Restated Certificate of Incorporation of Firefly Neuroscience, Inc.
(incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 12, 2024).
+Added: Certificate of Amendment No.1 of Amended and Restated Certificate of Incorporation of Firefly Neuroscience, Inc.
+Added: (incorporated herein by reference to Exhibit 3.2 to the Company's Registration Statement on Form S-3, filed with the SEC on December 3, 2025).
Amended and Restated Bylaws of Firefly Neuroscience, Inc.
(incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the SEC on August 12, 2024).
−Removed: Amendment to Employment Agreement, dated August 29, 2025, by and between Deel Canada Services Inc.
−Removed: and Paul Krzywicki.(incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on September 5, 2025)
+Added: Form of Pre-Funded Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K, filed with the SEC on March 12, 2026).
+Added: Form of 150% Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K, filed with the SEC on March 12, 2026).
+Added: Form of 200% Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K, filed with the SEC on March 12, 2026).
+Added: Form of 150% Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 12, 2026).
+Added: Form of 200% Common Stock Purchase Warrant (incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the SEC on May 12, 2026).
+Added: ATM Agreement by and between Konik Capital Partners, LLC, a division of T.R.
+Added: Winston and Company, LLC, dated February 3, 2026 (incorporated herein by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K, filed with the SEC on February 4, 2026).
+Added: Addendum to Personal Employment, dated February 4, 2026, by and between Firefly Neuroscience Ltd.
+Added: and Gil Issachar (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on February 4, 2026).
+Added: Form of Securities Purchase Agreement between Firefly Neuroscience, Inc.
+Added: and the Investors, dated March 8, 2026 (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on March 12, 2026).
+Added: Form of Lock-Up Agreement between Firefly Neuroscience, Inc.
+Added: and the Investors, dated March 12, 2026 (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on March 12, 2026).
+Added: Form of Amended and Restricted Lock-Up Agreement between Firefly Neuroscience, Inc.
+Added: and the Investors, dated April 16, 2026 (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on April 22, 2026).
+Added: Securities Purchase Agreement between Firefly Neuroscience, Inc.
+Added: and the Investor, dated May 6, 2026 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on May 12, 2026).
Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
4 unchanged sentences
Inline XBRL Taxonomy Extension Schema Document.
−Removed: Taxonomy Extension Calculation Linkbase Document.
−Removed: Taxonomy Extension Definition Linkbase Document.
−Removed: Taxonomy Extension Label Linkbase Document.
−Removed: Taxonomy Extension Presentation Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Label Linkbase Document.
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
1 unchanged sentence
Furnished herewith.
−Removed: Pursuant to the requirements of the Securities
−Removed: Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized .
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized .
FIREFLY NEUROSCIENCE, INC.
−Removed: November 12, 2025
/s/ Greg Lipschitz
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.